Mount Sinai’s Dr. Scott Friedman Receives Honors at American Association for the Study of Liver Disease Annual Meeting
Scott L. Friedman, MD, Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai, received multiple honors at the American Association for the Study of Liver Disease (AASLD) Annual Meeting on November 14, 2016, in Boston: He received the Distinguished Achievement Award of AASLD and the Distinguished Scientific Achievement Award of the American Liver Foundation, and delivered the Hans Popper Basic Science State-of-the-Art Lecture in Research. Dr. Friedman is the first individual to be honored in these ways at one meeting.
An internationally renowned physician-scientist, Dr. Friedman holds eight patents and has published more than 300 peer-reviewed publications. He formerly served as an Associate Editor of Hepatology and is currently a Scientific Advisor to Science Translational Medicine. He is also a past president of AASLD and a Fellow of the American Association for the Advancement of Science.
Under Dr. Friedman’s leadership, Mount Sinai’s Division of Liver Diseases has grown into the largest liver medicine program in the United States, incorporating the largest clinical liver fellowship training program in the country, a postdoctoral fellowship training grant supported by the National Institutes of Health (NIH), and a National Cancer Institute-sponsored Liver Cancer Program under The Tisch Cancer Institute at Mount Sinai.
Dr. Friedman’s additional past honors and awards include the European Association for the Study of Liver Diseases International Recognition Award, the Falk Foundation’s International Hans Popper Award, the Shanghai Magnolia Gold Award, the China Friendship Award, and Mount Sinai’s Jacobi Medallion.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.